Previous close | 15.13 |
Open | 15.28 |
Bid | 15.07 x 200 |
Ask | 15.13 x 100 |
Day's range | 14.94 - 15.35 |
52-week range | 11.09 - 17.77 |
Volume | |
Avg. volume | 1,344,646 |
Market cap | 1.782B |
Beta (5Y monthly) | 0.88 |
PE ratio (TTM) | 23.97 |
EPS (TTM) | 0.63 |
Earnings date | 08 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 26.71 |
The Company will Host a Conference Call and Webcast on Thursday, May 9, 2024, at 8:30 AM ETCORAL GABLES, Fla., April 22, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult-to-treat diseases, today announced that it will release its first quarter 2024 financial results after the market close
Key Insights Given the large stake in the stock by institutions, Catalyst Pharmaceuticals' stock price might be...
In this article, we will take a detailed look at Jim Cramer’s 10 Favorite Healthcare Stock Picks in 2024. For a quick overview of such stocks, read our article Jim Cramer’s 5 Favorite Healthcare Stock Picks in 2024. Jim Cramer kicked off 2024 with a positive note for the healthcare sector, saying in a program in January that the […]